Balaji Amines Limited

BALAMINES

INE050E01027

Specialty Chemicals

Market Closed - Bombay S.E. Other stock markets 06:00:47 2024-04-25 am EDT			5-day change	1st Jan Change
2,236 ^INR	-0.44%		+0.42%	-16.20%

Mar. 14	India Ratings Keeps Balaji Amines Rating at AA; Outlook Stable	MT
Jan. 31	Balaji Amines Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Balaji Amines Ltd. to Set Up New Plant for Manufacture of Morpholine at Unit-III

July 30, 2016 at 10:01 am EDT

Balaji Amines Ltd. announced that the board of directors at its meeting held on July 30, 2016, the board has taken a decision to set up a new plant for manufacture of Morpholine at unit-III with an installed capacity of 10,000 MTPA.

Latest news about Balaji Amines Limited

India Ratings Keeps Balaji Amines Rating at AA; Outlook Stable	Mar. 14	MT
Balaji Amines Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 31	CI
Balaji Amines Begins Commercial Production of N-Butylamines at Maharashtra Unit	Jan. 16	MT
Transcript : Balaji Amines Limited, Q2 2024 Earnings Call, Nov 10, 2023	Nov. 10
Balaji Amines Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 08	CI
Balaji Amines Arm Balaji Speciality Chemicals Withdraws Filing for IPO	23-09-11	MT
Transcript : Balaji Amines Limited, Q1 2024 Earnings Call, Sep 08, 2023	23-09-08
Balaji Amines Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-31	CI
Transcript : Balaji Amines Limited, Q4 2023 Earnings Call, May 22, 2023	23-05-22
Balaji Amines Limited Announces Resignation of Hemanth Reddy Gaddam as Chief Financial Officer	23-05-22	CI
Balaji Amines CFO Resigns	23-05-21	MT
Balaji Amines Limited Announces Board Changes	23-05-20	CI
Balaji Amines Limited Appoints Ande Srinivas Reddy as CFO	23-05-20	CI
Balaji Amines Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-20	CI
Balaji Amines Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-06	CI
Balaji Amines Clocks Rise in Fiscal Q2 Consolidated Profit; Shares Slide 4%	22-10-27	MT
Balaji Amines Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-27	CI
Balaji Amines Begins Commercial Production of Dimethyl Carbonate at New Unit	22-09-26	MT
Balaji Amines Limited Intimation of Commencement of Commercial Production of DMC at MIDC, Chincholi, Solapur	22-09-26	CI
Balaji Amines Commissions New Greenfield Unit in Maharashtra, India; Starts Construction of Two New Plants	22-09-14	MT
Balaji Amines Limited Completes Phase 1 of Greenfield Project	22-09-14	CI
Balaji Amines Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-12	CI
Balaji Amines Subsidiary Files Draft Papers for IPO	22-08-11	MT
Transcript : Balaji Amines Limited, Q4 2022 Earnings Call, May 12, 2022	22-05-12
Balaji Amines Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-11	CI

Chart Balaji Amines Limited

Duration

Period

More charts

Company Profile

Balaji Amines Limited is an India-based company, which is engaged in the business of manufacturing of specialty chemicals, aliphatic amines and derivatives. The Companyâs segments include Amines & Specialty Chemicals and Hotel Division. It also owns a five-star Hotel in Solapur, Maharashtra. Its products include amines, derivatives, specialty chemicals and pharma excipients. Its amine products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA), TRIMETHYLAMINE and others. Its specialty chemical products include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE (2-P), N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and others. Its derivatives products include Di-Methyl Acetamide (DMAC); Di-Methyl Amine Hydrochloride (DMA HCL); Tri-Methyl Amine Hydrochloride (TMA HCL); Di-Ethyl Amine Hydrochloride (DEA HCL), and others. Its pharma excipients products include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.

Sector

Specialty Chemicals

Calendar

2024-05-15 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Balaji Amines Limited

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2,246 INR

Average target price

2,742 INR

Spread / Average Target

+22.08%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
BALAJI AMINES LIMITED	-16.20%	873M
ECOLAB INC.	+10.86%	63.12B
GIVAUDAN SA	+12.69%	40.45B
FUJIFILM HOLDINGS CORPORATION	+17.66%	26.45B
EMS-CHEMIE HOLDING AG	+4.77%	18.31B
CELANESE CORPORATION	-1.17%	17.34B
POSCO FUTURE M CO., LTD.	-21.87%	16.71B
SYMRISE AG	+0.28%	15.55B
ALBEMARLE CORPORATION	-21.85%	13.55B
NITTO DENKO CORPORATION	+31.94%	12.94B

Other Specialty Chemicals

Balaji Amines Limited

Equities

BALAMINES

INE050E01027

Specialty Chemicals

Balaji Amines Ltd. to Set Up New Plant for Manufacture of Morpholine at Unit-III

Latest news about Balaji Amines Limited

Chart Balaji Amines Limited

Company Profile

Income Statement Evolution

Ratings for Balaji Amines Limited

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Specialty Chemicals